From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals last month.

Continue » The leader in diabetes and obesity Despite Lilly's huge success in treating diabetes and obesity, it's not the ...

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

When Health Secretary Robert F. Kennedy Jr. announced sweeping job cuts at his department last month, he said that safety ...

No other victims have been identified in connection with a seemingly unmotivated needle attack on a record shop owner, police ...